VeriMomnicotinamide mononucleotide est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or CIR/SCCS reproductive warnings were identified for nicotinamide mononucleotide. Authoritative cosmetic safety assessments (CIR/SCCS) do not list NMN as a reproductive hazard, and PubChem/ECHA registration summaries do not report harmonised reproductive classifications. Peer-reviewed literature on NMN focuses on metabolic and ageing effects rather than teratogenicity, with no confirmed human reproductive risk reported.
Related ingredients
Frequently asked questions
- nicotinamide mononucleotide est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or CIR/SCCS reproductive warnings were identified for nicotinamide mononucleotide. Authoritative cosmetic safety assessments (CIR/SCCS) do not list NMN as a reproductive hazard, and PubChem/ECHA registration summaries do not report harmonised reproductive classifications. Peer-reviewed literature on NMN focuses on metabolic and ageing effects rather than teratogenicity, with no confirmed human reproductive risk reported.
- nicotinamide mononucleotide est-il sûr pendant l'allaitement ?
- No regulatory or authoritative sources (ECHA Annex VI, CIR, SCCS) identify NMN as a lactation/breastfeeding hazard. There is no evidence of human breastmilk transfer or lactation-specific adverse effects in available summaries; no harmonised classification for reproductive/lactation toxicity exists.
- nicotinamide mononucleotide est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no infant-specific reproductive or endocrine hazards identified in authoritative sources. Exposure: NMN is a small, hydrophilic NAD+ precursor (not a highly lipophilic, high-penetration molecule); dermal absorption from topical use is expected to be low in adults, but per instruction infant exposure score is increased by +1 to account for higher surface-area-to-weight and immature barrier, giving a low but measurable exposure for 0–3 yr skin.
- Comment VeriMom évalue-t-il nicotinamide mononucleotide ?
- VeriMom évalue nicotinamide mononucleotide à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à nicotinamide mononucleotide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à nicotinamide mononucleotide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.